Artificial intelligence disease detection and care coordination platform Viz.ai announced Thursday it is partnering with neuroimaging and quantitative analysis solutions platform Cortechs.ai to exp | The collaboration will begin with a focus on multiple sclerosis, expanding access to quantitative neuroimaging for healthcare facilities across the U.S.

Artificial intelligence disease detection and care coordination platform Viz.ai announced Thursday it is partnering with neuroimaging and quantitative analysis solutions platform…

Viz.ai , il leader nel rilevamento di malattie e nel coordinamento intelligente dell'assistenza potenziati dall'intelligenza artificiale, oggi ha annunciato una collaborazione con…

The partnership brings quantitative MRI into real-time clinical workflows, helping neurologists track disease progression and make treatment decisions.